TAGE Score for Symptomatic Intracranial Hemorrhage Prediction After Successful Endovascular Treatment in Acute Ischemic Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 15 6 2022
medline: 25 8 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Determine if early venous filling (EVF) after complete successful recanalization with mechanical thrombectomy in acute ischemic stroke is an independent predictor of symptomatic intracranial hemorrhage (sICH) and integrate EVF into a risk score for sICH prediction. Consecutive patients with anterior acute ischemic stroke treated by mechanical thrombectomy issued from patients enrolled in the THRACE trial (Thrombectomie des Artères Cérébrales) and from 2 prospective registries were included and divided into a derivation (Center I; n=402) and validation cohorts (THRACE and center 2; n=507). EVF was evaluated by 2 blinded readers. sICH was defined according to the modified European cooperative acute stroke study II. Clinical and radiological data were analyzed in the derivation cohort (C1) to identify independent predictors of sICH and construct a predictive score test on the validation cohort (THRACE + C2). Symptomatic ICH rate was similar between the two cohorts (9.9% and 8.9% respectively, Time-Alberta Stroke Program Early CT-Glycemia-EVF score is a simple tool with readily available clinical variables with good performances for sICH prediction after mechanical thrombectomy. URL: https://www. gov; Unique identifier: NCT01062698.

Sections du résumé

BACKGROUND
Determine if early venous filling (EVF) after complete successful recanalization with mechanical thrombectomy in acute ischemic stroke is an independent predictor of symptomatic intracranial hemorrhage (sICH) and integrate EVF into a risk score for sICH prediction.
METHODS
Consecutive patients with anterior acute ischemic stroke treated by mechanical thrombectomy issued from patients enrolled in the THRACE trial (Thrombectomie des Artères Cérébrales) and from 2 prospective registries were included and divided into a derivation (Center I; n=402) and validation cohorts (THRACE and center 2; n=507). EVF was evaluated by 2 blinded readers. sICH was defined according to the modified European cooperative acute stroke study II. Clinical and radiological data were analyzed in the derivation cohort (C1) to identify independent predictors of sICH and construct a predictive score test on the validation cohort (THRACE + C2).
RESULTS
Symptomatic ICH rate was similar between the two cohorts (9.9% and 8.9% respectively,
CONCLUSIONS
Time-Alberta Stroke Program Early CT-Glycemia-EVF score is a simple tool with readily available clinical variables with good performances for sICH prediction after mechanical thrombectomy.
REGISTRATION
URL: https://www.
CLINICALTRIALS
gov; Unique identifier: NCT01062698.

Identifiants

pubmed: 35698971
doi: 10.1161/STROKEAHA.121.038088
doi:

Substances chimiques

Blood Glucose 0

Banques de données

ClinicalTrials.gov
['NCT01062698']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2809-2817

Auteurs

Paul Janvier (P)

Department of Neuroradiology (P.J., B.K., J.B., L.L., C.O., O.N., W.B.H.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Basile Kerleroux (B)

Department of Neuroradiology (P.J., B.K., J.B., L.L., C.O., O.N., W.B.H.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Guillaume Turc (G)

Neurology (G.T.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Marco Pasi (M)

Department of Neurology (M.P., H.H.), Lille University, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, France.

Wassim Farhat (W)

Department of Neurology, Saint-Joseph Hospital, Paris, France (W.F.).

Nicolas Bricout (N)

Department of Interventional Neuroradiology (N.B.), Lille University, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, France.

Joseph Benzakoun (J)

Department of Neuroradiology (P.J., B.K., J.B., L.L., C.O., O.N., W.B.H.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Laurence Legrand (L)

Department of Neuroradiology (P.J., B.K., J.B., L.L., C.O., O.N., W.B.H.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Frédéric Clarençon (F)

Department of Neuroradiology, Sorbonne University, AP-HP, Pitié Salpêtrière - Charles Foix Hospital, Paris, France (F.C.).

Serge Bracard (S)

Department of Neuroradiology, Nancy University (S.B.).

Catherine Oppenheim (C)

Department of Neuroradiology (P.J., B.K., J.B., L.L., C.O., O.N., W.B.H.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Grégoire Boulouis (G)

Diagnostic and Interventional Neuroradiology Department, INSERM U1253 iBrain, University Hospital of Tours, Centre Val de Loire Region, France (G.B.).

Hilde Henon (H)

Department of Neurology (M.P., H.H.), Lille University, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, France.

Olivier Naggara (O)

Department of Neuroradiology (P.J., B.K., J.B., L.L., C.O., O.N., W.B.H.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Wagih Ben Hassen (W)

Department of Neuroradiology (P.J., B.K., J.B., L.L., C.O., O.N., W.B.H.), Université de Paris, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH